Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
I think you covered most of the interesting points there Bman,
Just would add confirmation that the £10mil raise may be for equity stake in smaller projects (said at least twice) so not for Billingham etc which would eat too much of this/put too many eggs in one basket.
Also let slip Italy in terms of projects (at 50mins ish): please correct me if wrong but I don’t recall any Italian projects before? More news in the offing?
Thank you dsfat,
Another interview... Bit of fluff at the beginning before Raul gets into his stride:
https://www.zerohedge.com/markets/raoul-pal-biggest-trade-world
Dear Rouley,
Please be assured I didn’t suspect you were critical of the EQT management.
I have pretty much the same investment strategy; bought a somewhat crazy amount at the beginning of the year because I couldn’t see why this remained so undervalued with the new management team and strategy... Other than the ‘stale bull’ argument which befalls so many AIM companies, typically just before they come good. So this has done well since then but still a very long way to go if they can execute the plan during these troubled times. I remain very ‘overweight’!
Rouley,
Sorry, I would add I have an infinite greater respect for the management team at EQT... ITM are run by buffoons, the Linde man on the board must be pulling his/her hair out by now! And fwiw I have plenty of skin in the game here because of the potential.
Rouley,
Completely agree, and I assume that is the while purpose of the Wood collaboration. The only other way to prove viability /potential is to get more of the systems built and commissioned; but I suspect a collaboration with Wood/others would be quicker.
I want the ground to be broken!
ITM’s collaboration with Shell was not really the sp rise catalyst though was it, more the tie up with Linde (and equity stake). Did better investment wise though 13p to £1 or so but still only 1/3 of what could have been....
Thank you Kiwi,
A very interesting article. At least partially explains the different feel of this rally: volume better, sentiment better, decoupled from Share indices and even to a minor extent from other crypto.
Not very many PIs can shell out that sort of cash per transaction...
Indeed regarding the selling... But I took the opportunity to buy another 85k shares. Must be knocking on 0.75% of the company now!
Good to see the btc price increasing on good volumes, will eventually catch up hear once the style bulls are out of the way.
There may well be some just moving to cash before the us election. Personally this is part of my hedge for that very event.
I think it will be closer than the polls suggesting a Biden win: I would much prefer a clear winner!
Like the last UK election a silent majority will continue to vote right/democrat (and even his vote may increase due again to silent further objection to the liberal BLM riots.) Please don’t misunderstand these are not my views but just a repeat of the Hilary/Trump contest - the Left continually misunderstands the need to appeal to the moderate voter to win. Just as Boris won in the Midland/North traditional Labour seats, The Reps will take the swing states IMO.
I think the FDA will continue to function whatever happens!
Palumbo as you probably appreciate is from a venture Capital background so I would imagine has contacts/mechanisms under consideration to provide the finance. My impression is that the cash is to get the first few projects Over the line, and the rest will look after themselves being much more cash generative than an equivalent renewable (tidal/wind) project. (Ref from long research note).
Best wishes
DD77,
I take your points. My opinion is that there need to be 1-2 big projects and perhaps 3-4 smaller teaching financial close and helpfully 1-2 of those commissioned/operational before that £10m runs out. At that point further financial close and maintenance fees kick in leading to the self sustaining cash cow this will eventually become... IMO!
Entelion,
An excellent post, much of which I agree with. Angle have plenty of irons in the fire the key is moving forward the most promising to clinical commercialisation and larger trials of efficacy which requires plenty of cash (shouldn’t be a problem post FDA) - so long as approved. I am not as confident as you are that the FDA is very objective with its analysis for non US companies... But since Angle is valued as if pending FDA approval didn’t even exist the risk:reward works for a reasonable investment.
Also a device like this has less expensive trials/hurdles to negotiate than a drug....
Plus to some extent the Boeing/CAA débâcle whilst not directly relevant to an FDA submission has probably focused the minds of those in semi-corrupt US institutions not to make the bias too obvious lest the decisions come back to haunt you.
The decline of the US as a world power as its previously world class institutions have been progressively corrupted is an interesting debate - it’s fairly obvious where I sit on that one!